Passage Bio to Participate in Upcoming Investor Conferences

Company Overview - Passage Bio, Inc. is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases [2] - The company is developing cutting-edge, one-time therapies aimed at addressing the underlying pathology of neurodegenerative conditions [2] Upcoming Events - Management will participate in the Canaccord Genuity 44th Annual Growth Conference on August 13, 2024, at 8:00 a.m. ET in Boston, MA [1] - Management will also participate in the 15th Annual Wedbush PacGrow Healthcare Conference on August 14, 2024, in New York City, NY [1] - A live webcast of the presentation will be available on the company's website, with a replay accessible for 30 days post-event [1]